High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction

Abstract Aims The impacts of high density lipoprotein cholesterol (HDL‐C) as an anti‐inflammatory and C reactive protein (CRP) as inflammatory properties on the pathogenesis of heart failure were reported. At present, the clinical significance of the HDL‐C/CRP ratio in heart failure with preserved e...

Full description

Bibliographic Details
Main Authors: Masamichi Yano, Masami Nishino, Kohei Ukita, Akito Kawamura, Hitoshi Nakamura, Yutaka Matsuhiro, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Akihiro Tanaka, Yasuharu Matsunaga‐Lee, Yasuyuki Egami, Ryu Shutta, Jun Tanouchi, Takahisa Yamada, Yoshio Yasumura, Shunsuke Tamaki, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Shinichiro Suna, Daisaku Nakatani, Shungo Hikoso, Yasushi Sakata, Osaka CardioVascular Conference (OCVC)‐Heart Failure Investigators
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13350
id doaj-000113fefae746f285bb0244e5177907
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Masamichi Yano
Masami Nishino
Kohei Ukita
Akito Kawamura
Hitoshi Nakamura
Yutaka Matsuhiro
Koji Yasumoto
Masaki Tsuda
Naotaka Okamoto
Akihiro Tanaka
Yasuharu Matsunaga‐Lee
Yasuyuki Egami
Ryu Shutta
Jun Tanouchi
Takahisa Yamada
Yoshio Yasumura
Shunsuke Tamaki
Takaharu Hayashi
Akito Nakagawa
Yusuke Nakagawa
Shinichiro Suna
Daisaku Nakatani
Shungo Hikoso
Yasushi Sakata
Osaka CardioVascular Conference (OCVC)‐Heart Failure Investigators
spellingShingle Masamichi Yano
Masami Nishino
Kohei Ukita
Akito Kawamura
Hitoshi Nakamura
Yutaka Matsuhiro
Koji Yasumoto
Masaki Tsuda
Naotaka Okamoto
Akihiro Tanaka
Yasuharu Matsunaga‐Lee
Yasuyuki Egami
Ryu Shutta
Jun Tanouchi
Takahisa Yamada
Yoshio Yasumura
Shunsuke Tamaki
Takaharu Hayashi
Akito Nakagawa
Yusuke Nakagawa
Shinichiro Suna
Daisaku Nakatani
Shungo Hikoso
Yasushi Sakata
Osaka CardioVascular Conference (OCVC)‐Heart Failure Investigators
High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
ESC Heart Failure
Heart failure with preserved ejection fraction
Inflammation
High density lipoprotein cholesterol/C reactive protein ratio
Left ventricular diastolic function
Right ventricular systolic function
author_facet Masamichi Yano
Masami Nishino
Kohei Ukita
Akito Kawamura
Hitoshi Nakamura
Yutaka Matsuhiro
Koji Yasumoto
Masaki Tsuda
Naotaka Okamoto
Akihiro Tanaka
Yasuharu Matsunaga‐Lee
Yasuyuki Egami
Ryu Shutta
Jun Tanouchi
Takahisa Yamada
Yoshio Yasumura
Shunsuke Tamaki
Takaharu Hayashi
Akito Nakagawa
Yusuke Nakagawa
Shinichiro Suna
Daisaku Nakatani
Shungo Hikoso
Yasushi Sakata
Osaka CardioVascular Conference (OCVC)‐Heart Failure Investigators
author_sort Masamichi Yano
title High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
title_short High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
title_full High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
title_fullStr High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
title_full_unstemmed High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
title_sort high density lipoprotein cholesterol / c reactive protein ratio in heart failure with preserved ejection fraction
publisher Wiley
series ESC Heart Failure
issn 2055-5822
publishDate 2021-08-01
description Abstract Aims The impacts of high density lipoprotein cholesterol (HDL‐C) as an anti‐inflammatory and C reactive protein (CRP) as inflammatory properties on the pathogenesis of heart failure were reported. At present, the clinical significance of the HDL‐C/CRP ratio in heart failure with preserved ejection fraction (HFpEF) patients remains unknown. Methods and results We examined the data on 796 consecutive HFpEF (left ventricular ejection fraction ≥50%) patients hospitalized due to acute decompensated heart failure from the PURSUIT‐HFpEF registry, a prospective, multicentre observational study. We calculated the HDL/CRP ratios and evaluated the relationship between the values and clinical outcomes, including degree of cardiac function. The mean follow‐up duration was 420 ± 346 days. All‐cause death occurred in 118 patients, of which 51 were cardiac deaths. HDL/CRP ≤ 4.05 was independently and significantly associated with all‐cause death (odds ratio = 1.84, 95% CI: 1.06–3.20, P = 0.023), and HDL/CRP ≤ 3.14 was associated with cardiac death by multivariate Cox proportional hazard analysis (odds ratio = 2.86, 95% CI: 1.36–6.01, P = 0.003). HDL‐C/CRP ratio significantly correlated with the product of the left atrial volume and left ventricular mass index as well as the tricuspid annular plane systolic excursion by multiple regression analysis (standardized beta‐coefficient = −0.085, P = 0.034 and standardized beta‐coefficient = 0.081, P = 0.044, respectively). Conclusions HDL‐C/CRP ratio was a useful marker for predicting all‐cause death and cardiac death and correlated with left ventricular diastolic function and right ventricular systolic function in HFpEF patients.
topic Heart failure with preserved ejection fraction
Inflammation
High density lipoprotein cholesterol/C reactive protein ratio
Left ventricular diastolic function
Right ventricular systolic function
url https://doi.org/10.1002/ehf2.13350
work_keys_str_mv AT masamichiyano highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT masaminishino highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT koheiukita highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT akitokawamura highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT hitoshinakamura highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT yutakamatsuhiro highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT kojiyasumoto highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT masakitsuda highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT naotakaokamoto highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT akihirotanaka highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT yasuharumatsunagalee highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT yasuyukiegami highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT ryushutta highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT juntanouchi highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT takahisayamada highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT yoshioyasumura highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT shunsuketamaki highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT takaharuhayashi highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT akitonakagawa highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT yusukenakagawa highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT shinichirosuna highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT daisakunakatani highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT shungohikoso highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT yasushisakata highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
AT osakacardiovascularconferenceocvcheartfailureinvestigators highdensitylipoproteincholesterolcreactiveproteinratioinheartfailurewithpreservedejectionfraction
_version_ 1721265326712160256
spelling doaj-000113fefae746f285bb0244e51779072021-07-28T18:55:36ZengWileyESC Heart Failure2055-58222021-08-01842791280110.1002/ehf2.13350High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fractionMasamichi Yano0Masami Nishino1Kohei Ukita2Akito Kawamura3Hitoshi Nakamura4Yutaka Matsuhiro5Koji Yasumoto6Masaki Tsuda7Naotaka Okamoto8Akihiro Tanaka9Yasuharu Matsunaga‐Lee10Yasuyuki Egami11Ryu Shutta12Jun Tanouchi13Takahisa Yamada14Yoshio Yasumura15Shunsuke Tamaki16Takaharu Hayashi17Akito Nakagawa18Yusuke Nakagawa19Shinichiro Suna20Daisaku Nakatani21Shungo Hikoso22Yasushi Sakata23Osaka CardioVascular Conference (OCVC)‐Heart Failure InvestigatorsDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka Rosai Hospital 3‐1179 Nagasonecho, Kita‐ku, Sakai Osaka 591‐8025 JapanDivision of Cardiology Osaka General Medical Center Osaka JapanDivision of Cardiology Amagasaki Chuo Hospital Amagasaki JapanDivision of Cardiology Osaka General Medical Center Osaka JapanCardiovascular Division Osaka Police Hospital Osaka JapanDivision of Cardiology Amagasaki Chuo Hospital Amagasaki JapanDivision of Cardiology Kawanishi City Hospital Kawanishi JapanDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita JapanDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita JapanAbstract Aims The impacts of high density lipoprotein cholesterol (HDL‐C) as an anti‐inflammatory and C reactive protein (CRP) as inflammatory properties on the pathogenesis of heart failure were reported. At present, the clinical significance of the HDL‐C/CRP ratio in heart failure with preserved ejection fraction (HFpEF) patients remains unknown. Methods and results We examined the data on 796 consecutive HFpEF (left ventricular ejection fraction ≥50%) patients hospitalized due to acute decompensated heart failure from the PURSUIT‐HFpEF registry, a prospective, multicentre observational study. We calculated the HDL/CRP ratios and evaluated the relationship between the values and clinical outcomes, including degree of cardiac function. The mean follow‐up duration was 420 ± 346 days. All‐cause death occurred in 118 patients, of which 51 were cardiac deaths. HDL/CRP ≤ 4.05 was independently and significantly associated with all‐cause death (odds ratio = 1.84, 95% CI: 1.06–3.20, P = 0.023), and HDL/CRP ≤ 3.14 was associated with cardiac death by multivariate Cox proportional hazard analysis (odds ratio = 2.86, 95% CI: 1.36–6.01, P = 0.003). HDL‐C/CRP ratio significantly correlated with the product of the left atrial volume and left ventricular mass index as well as the tricuspid annular plane systolic excursion by multiple regression analysis (standardized beta‐coefficient = −0.085, P = 0.034 and standardized beta‐coefficient = 0.081, P = 0.044, respectively). Conclusions HDL‐C/CRP ratio was a useful marker for predicting all‐cause death and cardiac death and correlated with left ventricular diastolic function and right ventricular systolic function in HFpEF patients.https://doi.org/10.1002/ehf2.13350Heart failure with preserved ejection fractionInflammationHigh density lipoprotein cholesterol/C reactive protein ratioLeft ventricular diastolic functionRight ventricular systolic function